105 related articles for article (PubMed ID: 6134631)
1. Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils.
Jouvin-Marche E; Cerrina J; Coëffier E; Duroux P; Benveniste J
Eur J Pharmacol; 1983 Apr; 89(1-2):19-26. PubMed ID: 6134631
[TBL] [Abstract][Full Text] [Related]
2. Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.
Wade PJ; Lunt DO; Lad N; Tuffin DP; McCullagh KG
Thromb Res; 1986 Jan; 41(2):251-62. PubMed ID: 3961730
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF-acether), an activator of neutrophil functions.
Jouvin-Marche E; Poitevin B; Benveniste J
Agents Actions; 1982 Dec; 12(5-6):716-20. PubMed ID: 6299078
[TBL] [Abstract][Full Text] [Related]
4. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether.
Bureau M; Joseph D; Vargaftig BB
Prostaglandins; 1987 Jan; 33(1):37-50. PubMed ID: 3035615
[TBL] [Abstract][Full Text] [Related]
5. Measurement of ionized cytoplasmic calcium mobilization with the photoprotein aequorin in human polymorphonuclear leukocytes activated by platelet activating factor (PAF).
Del Maschio A; Albors M; Evangelista V; Bucchi F; Bertelé V; Cerletti C; de Gaetano G
J Lipid Mediat; 1989; 1(1):25-36. PubMed ID: 2562430
[TBL] [Abstract][Full Text] [Related]
6. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of platelet-activating factor from human polymorphonuclear leukocytes: regulation and pharmacological approaches.
Sánchez Crespo M; Alonso F; García Gil M; Gómez-Cambronero J; Nieto ML
Int J Tissue React; 1985; 7(5):345-9. PubMed ID: 2997066
[TBL] [Abstract][Full Text] [Related]
8. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists.
Yousufzai SY; Abdel-Latif AA
Biochem J; 1985 Jun; 228(3):697-706. PubMed ID: 3927898
[TBL] [Abstract][Full Text] [Related]
9. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
Koike H; Imanishi N; Natsume Y; Morooka S
Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
[TBL] [Abstract][Full Text] [Related]
10. Effect of synthetic PAF-acether on human neutrophil function.
Czarnetzki BM; Benveniste J
Agents Actions; 1981 Dec; 11(6-7):549-50. PubMed ID: 7041568
[TBL] [Abstract][Full Text] [Related]
11. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
12. Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular Ca2+.
Ludwig JC; McManus LM; Clark PO; Hanahan DJ; Pinckard RN
Arch Biochem Biophys; 1984 Jul; 232(1):102-10. PubMed ID: 6430234
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists.
Selak MA; Smith JB
J Lipid Mediat; 1989; 1(2):125-37. PubMed ID: 2519888
[TBL] [Abstract][Full Text] [Related]
14. Evidence that biosynthesis of platelet-activating factor (paf-acether) by human neutrophils occurs in an intracellular membrane.
Ribbes G; Ninio E; Fontan P; Record M; Chap H; Benveniste J; Douste-Blazy L
FEBS Lett; 1985 Oct; 191(2):195-9. PubMed ID: 3932094
[TBL] [Abstract][Full Text] [Related]
15. Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes.
Elferink JG
Arzneimittelforschung; 1982; 32(11):1417-20. PubMed ID: 6891245
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes.
Filep JG; Földes-Filep E
Eur J Pharmacol; 1990 Nov; 190(1-2):67-73. PubMed ID: 1963851
[TBL] [Abstract][Full Text] [Related]
17. Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
Camussi G; Tetta C; Segoloni G; Chiara Deregibus M; Bussolino F
Agents Actions; 1981 Dec; 11(6-7):550-3. PubMed ID: 7041569
[TBL] [Abstract][Full Text] [Related]
18. Release of PAF-acether from human blood monocytes.
Arnoux B; Jouvin-Marche E; Arnoux A; Benveniste J
Agents Actions; 1982 Dec; 12(5-6):713-6. PubMed ID: 7164946
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cellular retention of paf-acether by extracellular pH and cell concentration.
Leyravaud S; Benveniste J
Biochim Biophys Acta; 1989 Sep; 1005(2):192-5. PubMed ID: 2775773
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
